Clinical Trial

Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis

Name: Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis — clinical trial record (NCT07734415)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety and efficacy of long-term treatment with IMG-007 in participants with moderate-to-severe atopic dermatitis (AD)

Trial Details

NCT Number	NCT07734415
Lead Sponsor	Inmagene LLC
Conditions	Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema
Enrollment	400 participants
Start Date	2026-06-05
Primary Completion	2028-03 (estimated)
Study Completion	2028-03 (estimated)
Updated on ClinicalTrials.gov	2026-07-29